Glioma Targeting and Anti-glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized Nanoparticles

E-ISSN： 1873-4316|14|13|1118-1126

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.13, 2013-11, pp. : 1118-1126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Integrins in Glioma Biology and Anti-Glioma Therapies

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2402-2410

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2428-2438

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 7, 2016-05 ,pp. : 636-650

Bentham Science Publishers

Access to resources Recommend Favorite

Integrin-Mediated Drug Delivery in Cancer and Cardiovascular Diseases with Peptide-Functionalized Nanoparticles

Current Medicinal Chemistry, Vol. 19, Iss. 19, 2012-07 ,pp. : 3128-3151

Bentham Science Publishers

Access to resources Recommend Favorite

Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 10, 2014-10 ,pp. : 752-758

Govi-Verlag

Access to resources Recommend Favorite